Skip to main content
. 2021 Mar 12;13(6):1244. doi: 10.3390/cancers13061244

Table 3.

Structures and potencies of the designed and synthesised ZVS -08 analogues 1–12.

Compound ID Structure % of Kv10.1 Inhibition at 10 μM
1 graphic file with name cancers-13-01244-i010.jpg 87.32 ± 4.60 (7)
2 graphic file with name cancers-13-01244-i011.jpg 23.93 ± 26.80 (4)
3 graphic file with name cancers-13-01244-i012.jpg 22.08 ± 33.52 (4)
4 graphic file with name cancers-13-01244-i013.jpg 36.63 ± 19.89 (7)
5 graphic file with name cancers-13-01244-i014.jpg 2.53 ± 11.73 (3)
6 graphic file with name cancers-13-01244-i015.jpg 57.48 ± 28.38 (3)
7 graphic file with name cancers-13-01244-i016.jpg 20.96 ± 30.27 (7)
8 graphic file with name cancers-13-01244-i017.jpg 81.20 ± 4.97 (3)
9 graphic file with name cancers-13-01244-i018.jpg 2.00 ± 7.45 (4)
10 graphic file with name cancers-13-01244-i019.jpg 57.05 ± 21.71 (2)
11 graphic file with name cancers-13-01244-i020.jpg 37.67 ± 7.13 (2)
12 graphic file with name cancers-13-01244-i021.jpg 16.60 ± 38.36 (2)

Inhibition data are means ± standard error (or range) for the number of independent experiments indicated in parentheses.